{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T21:51:39Z","timestamp":1771365099125,"version":"3.50.1"},"reference-count":22,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1002\/ajh.27437","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T04:51:22Z","timestamp":1721710282000},"page":"2041-2044","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Network meta\u2010analysis of upfront fixed\u2010duration therapies in chronic lymphocytic leukemia"],"prefix":"10.1002","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2795-6507","authenticated-orcid":false,"given":"Stefano","family":"Molica","sequence":"first","affiliation":[{"name":"Department of Hematology Hull University Teaching Hospitals NHS Trust  Hull UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6159-6109","authenticated-orcid":false,"given":"David","family":"Allsup","sequence":"additional","affiliation":[{"name":"Department of Hematology Hull University Teaching Hospitals NHS Trust  Hull UK"},{"name":"Centre for Biomedicine Hull York Medical School  Hull UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Giannarelli","sequence":"additional","affiliation":[{"name":"Biostatistics Unit Scientific Directorate Fondazione Policlinico Universitario Agostino Gemelli IRCCS  Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"e_1_2_1_6_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2020.1724282"},{"issue":"1","key":"e_1_2_1_6_3_1","first-page":"P670","article-title":"Final analysis of the RESONATE\u20102 study: up to 10\u2009years of follow\u2010up of first\u2010line ibrutinib treatment in patients with chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"8","author":"Burger J","year":"2024","journal-title":"HemaSphere"},{"key":"e_1_2_1_6_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000118"},{"key":"e_1_2_1_6_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006783"},{"key":"e_1_2_1_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00266-2"},{"key":"e_1_2_1_6_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713976"},{"key":"e_1_2_1_6_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1815281"},{"key":"e_1_2_1_6_9_1","article-title":"Final 7\u2010year follow\u2010up and retreatment substudy analysis of MURANO: venetoclax\u2010rituximab (venr)\u2010treated patients with relapsed\/refractory chronic lymphocytic leukemia (R\/R CLL)","volume":"7","author":"Kater A","year":"2023","journal-title":"Hema"},{"key":"e_1_2_1_6_10_1","article-title":"Venetoclax\u2010obinutuzumab for previously untreated chronic lymphocytic leukemia: 6\u2010year results of the randomized CLL14 study","volume":"7","author":"Al\u2010Sawaf O","year":"2023","journal-title":"Hema"},{"key":"e_1_2_1_6_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014488"},{"key":"e_1_2_1_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00452-7"},{"key":"e_1_2_1_6_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2310063"},{"key":"e_1_2_1_6_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900574"},{"key":"e_1_2_1_6_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00894"},{"key":"e_1_2_1_6_16_1","unstructured":"European Commission approves IMBRUVICA\u00ae (ibrutinib) in a fixed\u2010duration combination regimen for adult patients with previously untreated chronic lymphocytic leukaemia (CLL). News Release Johnson & Johnson August 4 2022. Accessed April 15 2024.https:\/\/bit.ly\/3AMP4yh"},{"key":"e_1_2_1_6_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1"},{"key":"e_1_2_1_6_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g5630"},{"key":"e_1_2_1_6_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213093"},{"key":"e_1_2_1_6_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-173709"},{"key":"e_1_2_1_6_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-177713"},{"key":"e_1_2_1_6_22_1","unstructured":"Lopez JimenezFJ RivasJAH vanSandenS et al.Cross\u2010study comparison of ibrutinib plus venetoclax (I+V) vs venetoclax plus Obinutuzumab (V+G) in subjects with previously untreated chronic lymphocytic leukemia (CLL) with comorbidities.https:\/\/library.ehaweb.org\/eha\/2024\/eha2024-congress\/419922\/francisco.javier.lopez.jimenez.crossstudy.comparison.of.ibrutinib.plus.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Ace_id%3D2552%2Aot_id%3D29194%2Amarker%3D5100%2Afeatured%3D18498"},{"key":"e_1_2_1_6_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2024.2366534"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.27437","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T04:19:53Z","timestamp":1759378793000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.27437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1002\/ajh.27437"],"URL":"https:\/\/doi.org\/10.1002\/ajh.27437","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"assertion":[{"value":"2024-05-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}